All mice treated with CD5 CAR-T and CD5CD7KO T cells progressed steadily, while CD7 CAR-T cells were able to temporarily inhibit neoplastic cells but failed to control the progression of leukemia due to the loss of CD7 antigen on tumor cells (Fig. 6d). The gene discussed is CD5; the disease is neoplasm.